Quick Takeaways
- Eric Benevich has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,530,915.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Eric Benevich
- Location
- San Diego, CA
- Summary
- The estimated net worth of Eric Benevich is at least $8,530,915 dollars as of 17 Feb 2026. Eric Benevich is the Chief Commercial Officer of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $8.53M.
- Signature
- /s/ Darin Lippoldt, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Eric Benevich and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: NEUROCRINE BIOSCIENCES INC ($8,530,915).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Eric Benevich
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Chief Commercial Officer | $8,530,915 | 12 Feb 2026 | ||
| ATYR | aTYR PHARMA INC | Director | 01 May 2025 |
Insider Transactions Reported by Eric Benevich:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.